This group comprises preparations used in the treatment of neoplastic diseases, and immunomodulating agents. Corticosteroids for systemic use, see H02.
L04 - Immunosuppressants
Immunosuppressants are defined as agents that completely or partly suppress one or more factors in the immunosystem.
L04A - Immunosuppressants
This group comprises immunosuppressants excl. corticosteroids.
The DDDs are based on prophylaxis of allograft transplant rejection if this is an approved indication.
L04AJ - Complement Inhibitors
The DDD for eculizumab is based on the dose given in the maintenance phase. The DDD for ravulizumab is based on SC injection.
